Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedUpgrade notice added about funding and operations; version updated to v3.2.0, replacing v3.1.0.SummaryDifference2%
- Check16 days agoChange DetectedRemoved detailed neoplasm and carcinoma terms and added a new revision tag: v3.1.0. This suggests a simplification or renaming of content with an updated version rather than adding substantive new material.SummaryDifference0.5%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdded: Revision v3.0.2; Removed: Revision v3.0.1 and Back to Top. No changes to core content, pricing, or stock.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has undergone significant updates, including the addition of new medical terms and conditions related to ovarian cancer and other diseases, while removing previous references to specific locations and certain genetic resources.SummaryDifference3%
- Check59 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.